SCHEMBL10325813

SCHEMBL10325813

CCCCCCCCC=CCCCCCCCCOP(=O)(OCCCCCCCCC=CCCCCCCCC)OCC[N+](C)(C)C

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.62
AKT1 P31749 2/20 0.62
ESR1 P03372 1/20 0.62
ADORA3 P0DMS8 1/20 0.62
CDC25A P30304 1/20 0.62
AGTR1 P30556 1/20 0.62
ADRA1A P35348 1/20 0.62
KCNH2 Q12809 1/20 0.62
LPAR3 Q9UBY5 7/20 0.55
LPAR2 Q9HBW0 5/20 0.55
LPAR1 Q92633 4/20 0.55
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
S1PR1 P21453 1/20 0.50
CYP3A4 P08684 1/20 0.48
ALDH1A1 P00352 2/20 0.48
PRKD3 O94806 1/20 0.46
PRKCG P05129 1/20 0.46
PRKCB P05771 1/20 0.46
PRKCA P17252 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29060954 0.90 LMNA (0.74) LMNAAKT1ESR1ADORA3CDC25A
SCHEMBL5822144 0.90 LMNA (0.74) LMNAAKT1ESR1ADORA3CDC25A
SCHEMBL22721395 0.90 LMNA (0.74) LMNAAKT1ESR1ADORA3CDC25A
SCHEMBL4981336 0.88 LPAR3 (0.68) LPAR3LPAR2LPAR1CYP3A4
SCHEMBL21439796 0.88 LPAR3 (0.68) LPAR3LPAR2LPAR1CYP3A4
SCHEMBL615756 0.88 LPAR3 (0.68) LPAR3LPAR2LPAR1CYP3A4
SCHEMBL21439794 0.88 LPAR3 (0.68) LPAR3LPAR2LPAR1CYP3A4
SCHEMBL6119544 0.88 LPAR3 (0.68) LPAR3LPAR2LPAR1CYP3A4
SCHEMBL7800702 0.88 LPAR3 (0.68) LPAR3LPAR2LPAR1CYP3A4
SCHEMBL28522407 0.88 LPAR3 (0.68) LPAR3LPAR2LPAR1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2642981-B1 SOLID DOSAGE FORMS OF OLEYL PHOSPHOCHOLINE OBLITA THERAPEUTICS BVBA (BE) 2017-05-17 EP claimed
EP-2663282-A2 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES, CANCER, OR SKIN DISEASES BY TOPICAL ADMINISTRATION Dafra Pharma Research & Development BVBA (BE) 2013-11-20 EP disclosed
EP-2642981-A1 SOLID DOSAGE FORMS OF OLEYL PHOSPHOCHOLINE Dafra Pharma Research & Development BVBA (BE) 2013-10-02 EP disclosed
WO-2012095500-A3 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES, CANCER, OR SKIN DISEASES BY TOPICAL ADMINISTRATION DAFRA PHARMA RESEARCH&DEVELOPMENT BVBA (BE) 2012-09-20 WO disclosed
WO-2012095500-A2 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES, CANCER, OR SKIN DISEASES BY TOPICAL ADMINISTRATION DAFRA PHARMA RESEARCH&DEVELOPMENT BVBA (BE) 2012-07-19 WO disclosed
WO-2012069427-A1 SOLID DOSAGE FORMS OF OLEYL PHOSPHOCHOLINE DAFRA PHARMA RESEARCH&DEVELOPMENT BVBA (BE) 2012-05-31 WO disclosed